|
VRK1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.221800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.926100E-02 |
| Normal-vs-Stage2 |
1.374010E-02 |
| Normal-vs-Stage3 |
8.320800E-03 |
| Normal-vs-Stage4 |
3.638200E-01 |
| Stage1-vs-Stage2 |
2.266200E-01 |
| Stage1-vs-Stage3 |
1.573810E-01 |
| Stage1-vs-Stage4 |
8.007000E-01 |
| Stage2-vs-Stage3 |
8.257200E-01 |
| Stage2-vs-Stage4 |
3.559400E-01 |
| Stage3-vs-Stage4 |
2.610600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.338280E-02 |
| Normal-vs-AfricanAmerican |
8.604300E-02 |
| Normal-vs-Asian |
9.615800E-01 |
| Caucasian-vs-AfricanAmerican |
8.620200E-01 |
| Caucasian-vs-Asian |
5.121600E-01 |
| AfricanAmerican-vs-Asian |
4.505800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.171720E-02 |
| Normal-vs-Female |
4.903800E-02 |
| Male-vs-Female |
4.823400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.949800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.027970E-01 |
| Normal-vs-Age(61-80Yrs) |
5.182000E-03 |
| Normal-vs-Age(81-100Yrs) |
7.024900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.643800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.461380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.757600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.232400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.996000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.095200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.665600E-01 |
| Normal-vs-Grade 2 |
1.368040E-01 |
| Normal-vs-Grade 3 |
5.045300E-04 |
| Normal-vs-Grade 4 |
3.053000E-01 |
| Grade 1-vs-Grade 2 |
2.415400E-01 |
| Grade 1-vs-Grade 3 |
6.079200E-03 |
| Grade 1-vs-Grade 4 |
1.997570E-01 |
| Grade 2-vs-Grade 3 |
4.783300E-03 |
| Grade 2-vs-Grade 4 |
7.946800E-01 |
| Grade 3-vs-Grade 4 |
3.079600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.981700E-02 |
| Normal-vs-ccB subtype |
2.782000E-02 |
| ccA subtype-vs-ccB subtype |
4.430800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.522200E-02 |
| Normal-vs-N1 |
4.504200E-02 |
| N0-vs-N1 |
3.320000E-01 |
|
|
